CO6382140A2 - Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada - Google Patents
Composiciones de vacuna que comprenden una proteina de enlace del factor h mutadaInfo
- Publication number
- CO6382140A2 CO6382140A2 CO11055224A CO11055224A CO6382140A2 CO 6382140 A2 CO6382140 A2 CO 6382140A2 CO 11055224 A CO11055224 A CO 11055224A CO 11055224 A CO11055224 A CO 11055224A CO 6382140 A2 CO6382140 A2 CO 6382140A2
- Authority
- CO
- Colombia
- Prior art keywords
- mutada
- vaccine compositions
- link protein
- compositions understanding
- factor link
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 108700041430 link Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 101710186862 Factor H binding protein Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0819633.9A GB0819633D0 (en) | 2008-10-25 | 2008-10-25 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6382140A2 true CO6382140A2 (es) | 2012-02-15 |
Family
ID=40133849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11055224A CO6382140A2 (es) | 2008-10-25 | 2011-05-05 | Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20120052092A1 (enExample) |
| EP (2) | EP2355845B1 (enExample) |
| JP (2) | JP5676458B2 (enExample) |
| KR (3) | KR20170000390A (enExample) |
| CN (2) | CN105412920A (enExample) |
| AU (1) | AU2009306114B2 (enExample) |
| BR (1) | BRPI0919926A2 (enExample) |
| CA (1) | CA2741619A1 (enExample) |
| CO (1) | CO6382140A2 (enExample) |
| DK (1) | DK3501534T5 (enExample) |
| ES (1) | ES2970878T3 (enExample) |
| FI (1) | FI3501534T3 (enExample) |
| GB (1) | GB0819633D0 (enExample) |
| HR (1) | HRP20240226T1 (enExample) |
| HU (1) | HUE065348T2 (enExample) |
| LT (1) | LT3501534T (enExample) |
| MX (1) | MX2011004322A (enExample) |
| NZ (2) | NZ592444A (enExample) |
| PL (1) | PL3501534T3 (enExample) |
| PT (1) | PT3501534T (enExample) |
| RU (1) | RU2559528C2 (enExample) |
| SI (1) | SI3501534T1 (enExample) |
| WO (1) | WO2010046715A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001031019A2 (en) | 1999-10-29 | 2001-05-03 | Chiron Spa | Neisserial antigenic peptides |
| EP2261350A3 (en) | 1998-05-01 | 2012-01-04 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
| EP2270172B1 (en) | 1999-05-19 | 2016-01-13 | GlaxoSmithKline Biologicals SA | Combination neisserial compositions |
| EP1261723B1 (en) | 2000-02-28 | 2008-02-27 | Novartis Vaccines and Diagnostics S.r.l. | Hybrid expression of neisserial proteins |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| NZ562998A (en) | 2002-10-11 | 2008-05-30 | Novartis Vaccines & Diagnostic | Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| WO2009104097A2 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
| ES2557282T3 (es) | 2008-03-10 | 2016-01-25 | Children's Hospital & Research Center At Oakland | Proteínas quiméricas de unión al factor H (fHBP) que contienen un dominio B heterólogo, y métodos de uso |
| CN104548082A (zh) | 2009-03-24 | 2015-04-29 | 诺华股份有限公司 | 为脑膜炎球菌因子h结合蛋白添加佐剂 |
| CA2759400A1 (en) | 2009-04-30 | 2010-11-04 | Children's Hospital & Research Center At Oakland | Chimeric factor h binding proteins (fhbp) and methods of use |
| CA2779816A1 (en) * | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
| CN102869378A (zh) * | 2010-03-10 | 2013-01-09 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
| EP4036104B1 (en) | 2010-03-30 | 2024-02-21 | Children's Hospital & Research Center at Oakland | Factor h binding proteins (fhbp) with altered properties and methods of use thereof |
| EP2585106A1 (en) | 2010-06-25 | 2013-05-01 | Novartis AG | Combinations of meningococcal factor h binding proteins |
| AU2013214105A1 (en) | 2012-02-02 | 2014-07-24 | Novartis Ag | Promoters for increased protein expression in meningococcus |
| BR112014031386A2 (pt) | 2012-06-14 | 2017-08-01 | Pasteur Institut | vacinas para meningococos do sorogrupo x |
| CN104736563A (zh) | 2012-07-27 | 2015-06-24 | 国家健康与医学研究院 | Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附 |
| US20160030544A1 (en) * | 2013-03-14 | 2016-02-04 | Isis Innovation Limited | Immunogenic composition to neisseria |
| MX2016001412A (es) | 2013-08-02 | 2016-10-28 | Children ' S Hospital & Res Center Oakland | Proteinas de union al factor h (fhbp) de origen no natural y métodos de uso de estas. |
| EA034954B1 (ru) | 2014-02-28 | 2020-04-10 | Глаксосмитклайн Байолоджикалс Са | МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp |
| EP3172224B1 (en) | 2014-07-23 | 2022-06-29 | Children's Hospital & Research Center at Oakland | Factor h binding protein variants and methods of use thereof |
| KR102709811B1 (ko) * | 2014-08-20 | 2024-09-24 | 스티흐팅 산퀸 불드포르지닝 | 인자 h 강화 항체 및 그의 용도 |
| GB201614687D0 (en) * | 2016-08-31 | 2016-10-12 | Univ Oxford Innovation Ltd | fHbp scaffold |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| EP3897706A4 (en) | 2018-12-21 | 2022-11-23 | Griffith University | COMPOSITIONS, METHODS AND USES FOR INDURING AN IMMUNE RESPONSE |
| EP3997108A4 (en) * | 2019-07-08 | 2024-03-20 | Crapaud Bio, Inc. | METHODS OF PRODUCING AND USING LIPOOLIGOSACCHARIDE COMPOSITIONS AND VACCINES |
| TWI851771B (zh) | 2019-07-17 | 2024-08-11 | 美商雙子治療子公司 | 因子ｈ增強抗體及其用途 |
| JP2024507828A (ja) | 2021-02-19 | 2024-02-21 | サノフィ パスツール インコーポレイテッド | Ｂ群髄膜炎菌組換えワクチン |
| TW202423477A (zh) | 2022-08-03 | 2024-06-16 | 美商賽諾菲巴斯德公司 | 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| US5476784A (en) * | 1993-04-06 | 1995-12-19 | Rice; Peter A. | Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| CN1867354A (zh) * | 2003-04-16 | 2006-11-22 | 惠氏控股有限公司 | 预防和治疗脑膜炎球菌疾病的新颖免疫原性组合物 |
| EP2682126B1 (en) * | 2005-01-27 | 2016-11-23 | Children's Hospital & Research Center at Oakland | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| WO2008001224A2 (en) * | 2006-06-29 | 2008-01-03 | Novartis Ag | Polypeptides from neisseria meningitidis |
| EP2470204B1 (en) * | 2009-08-27 | 2015-12-16 | GlaxoSmithKline Biologicals SA | Hybrid polypeptides including meningococcal fhbp sequences |
| EP4036104B1 (en) * | 2010-03-30 | 2024-02-21 | Children's Hospital & Research Center at Oakland | Factor h binding proteins (fhbp) with altered properties and methods of use thereof |
-
2008
- 2008-10-25 GB GBGB0819633.9A patent/GB0819633D0/en not_active Ceased
-
2009
- 2009-10-26 PT PT182096610T patent/PT3501534T/pt unknown
- 2009-10-26 HU HUE18209661A patent/HUE065348T2/hu unknown
- 2009-10-26 BR BRPI0919926A patent/BRPI0919926A2/pt not_active Application Discontinuation
- 2009-10-26 FI FIEP18209661.0T patent/FI3501534T3/fi active
- 2009-10-26 PL PL18209661.0T patent/PL3501534T3/pl unknown
- 2009-10-26 MX MX2011004322A patent/MX2011004322A/es active IP Right Grant
- 2009-10-26 EP EP09753188.3A patent/EP2355845B1/en not_active Not-in-force
- 2009-10-26 CA CA2741619A patent/CA2741619A1/en not_active Abandoned
- 2009-10-26 DK DK18209661.0T patent/DK3501534T5/da active
- 2009-10-26 KR KR1020167035443A patent/KR20170000390A/ko not_active Ceased
- 2009-10-26 KR KR1020117011885A patent/KR20110092282A/ko not_active Ceased
- 2009-10-26 AU AU2009306114A patent/AU2009306114B2/en not_active Ceased
- 2009-10-26 US US13/125,957 patent/US20120052092A1/en not_active Abandoned
- 2009-10-26 KR KR1020197002691A patent/KR20190011836A/ko not_active Ceased
- 2009-10-26 NZ NZ592444A patent/NZ592444A/xx unknown
- 2009-10-26 HR HRP20240226TT patent/HRP20240226T1/hr unknown
- 2009-10-26 WO PCT/GB2009/051439 patent/WO2010046715A1/en not_active Ceased
- 2009-10-26 EP EP18209661.0A patent/EP3501534B1/en active Active
- 2009-10-26 RU RU2011120706/10A patent/RU2559528C2/ru not_active IP Right Cessation
- 2009-10-26 ES ES18209661T patent/ES2970878T3/es active Active
- 2009-10-26 JP JP2011532725A patent/JP5676458B2/ja not_active Expired - Fee Related
- 2009-10-26 LT LTEP18209661.0T patent/LT3501534T/lt unknown
- 2009-10-26 CN CN201510119007.XA patent/CN105412920A/zh active Pending
- 2009-10-26 NZ NZ601538A patent/NZ601538A/en not_active IP Right Cessation
- 2009-10-26 CN CN2009801480003A patent/CN102245202A/zh active Pending
- 2009-10-26 SI SI200932190T patent/SI3501534T1/sl unknown
-
2011
- 2011-05-05 CO CO11055224A patent/CO6382140A2/es not_active Application Discontinuation
-
2014
- 2014-12-25 JP JP2014261910A patent/JP6076326B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6382140A2 (es) | Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada | |
| UA118332C2 (uk) | Білок, що зв'язує антиген cd27l | |
| CY1120413T1 (el) | Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου | |
| CR20110466A (es) | Anticuerpos biespecíficos anti-erbb-3/anti-c-met | |
| ECSP13011139A (es) | Anticuerpos contra la angiopoyetina 2 humana | |
| EA201001639A1 (ru) | Композиции и способы их получения и применения | |
| ECSP10010295A (es) | Formulacion de anticuerpo | |
| GT201100023A (es) | Anticuerpos neutralizantes del virus anti - influenza a y usos de los mismos | |
| BR112012008833A2 (pt) | imunoglobulinas de dominio variavel duplo e usos das mesmas | |
| MX353706B (es) | Anticuerpos contra csf-1r humano y usos de los mismos. | |
| CR20110166A (es) | Anticuerpos biespecíficos anti-vegf/anti-ang-2 | |
| CY1117563T1 (el) | Αντισωματα κατα her3 και χρησεις αυτων | |
| PH12014501835A1 (en) | Novel adjuvant compositions | |
| EA201591888A1 (ru) | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов | |
| BR112014015851A2 (pt) | proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17 | |
| CO6440541A2 (es) | Virus de diarrea viral bovina con una proteina erns modificada | |
| BR112015018270A2 (pt) | composições que compreendem 15-ohepa e métodos de uso das mesmas | |
| CR20110209A (es) | Composición farmacéutica sólida | |
| PE20081687A1 (es) | Proteina de fusion | |
| EA201790558A1 (ru) | Композиция с пониженной иммуногенностью | |
| BRPI0611820B8 (pt) | método de identificar uma infecção por e. canis ou e. chaffeensis | |
| BRPI0914940A8 (pt) | Composições nutritivas contendo punicalaginas | |
| BR112013003883A2 (pt) | composições que compreendem paulownina e/ou extratos de paulônia e usos das mesmas | |
| CR20130065A (es) | Composiciones de anticuertpo anti-vegfr-3 | |
| CR8617A (es) | Formulaciones de dispersiones solidas de acetato de bazedoxifeno |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |